Profit Margin (%) (27.2) 1.6 EBITDA Margin (%) (2.2) 6.8 Net profit Margin (%) (45.3) (1.4) Return on Equity (%) (25.2) (1.2) Efficiency Ratio Return on Assets (%) (11.2) (0.6) Return on Fixed Assets

for the year ended February 28, 2017 which were audited by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The Company has net profit attributed to owners of the parent of 2,403 million baht, a

Company has net profit attributed to owners of the parent of 987 million baht or 3.95 baht per share, showing a record growth rate of 6% y-y and 21% q-q. The financial performance can be summarized as

reviewed by the auditor as at June 30, 2018. The details on calculation of the value of the asset acquisition transaction are described below. Basis Formula Calculation Size 1. Net tangible asset – NTA) NTA

that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of

% 29.99 14.16 111.79% Net income 77.91 21.14 268.54% 201.68 34.31 487.82% Profit sharing Attributed to the shareholders of the company 56.16 27.54 103.92% 141.69 48.62 191.42% Attributed to the stakeholders

Ratio Gross Profit Margin (%) 12.9 27.5 Operating Profit Margin (%) 5.7 21.0 EBITDAR Margin (%) 18.4 30.2 Net profit Margin (%) 0.3 10.6 Return on Equity (%) 0.3 9.1 Efficiency Ratio Return on Assets

million baht or 72.9 percent. After corporate income tax, net profit was 263.7 million baht of which gain attributable to equity holders of the Company at the amount of 249.3 million baht. Earnings per

forward the efficiency improvement of ABP5 via LTSA with Siemens After ABP3 entered the additional Long Term Service Agreement (LTSA) with Siemens in December 2018 – January 2019 in order to improve

Discussion and Analysis EXECUTIVE SUMMARY SIGNIFICANT EVENTS New Capital Structure and Use of Proceed from IPO Regarding our IPO, we received net proceed from IPO in the amount of Baht 11,078 million composing